News Could phase 3 trial win save AZ's troubled Lupus drug? AstraZeneca has been on a hot streak of trial successes recently, with the latest win being in a late-stage study for a potential lupus drug that looked dead and buried after a major trial
News Roche's Gazyva shows promise in Lupus nephritis trial Roche’s Gazyva is already approved in leukaemia and lymphoma – but could it work in the autoimmune kidney disease Lupus nephritis too?
News FDA approves first treatment for children with lupus The US FDA has approved GSK’s Benlysta (belimumab) intravenous infusion for the treatment of children with lupus.
News AZ's lupus drug fails in late-stage trial AZ will launch full review after further phase 3 results later this year
News Just how radical is the FDA's complete response letter move? The FDA says publishing complete response letters for medicines is an act of "radical transparency," but it is not as revolutionary as it seems.
Market Access The value of a partner, globally and locally A new podcast looks at recent trends related to drug approvals, as well as challenges and opportunities both small and large pharma companies face
